Skip to main
MASI
MASI logo

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 42%
Buy 37%
Hold 21%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corporation's financial performance shows a positive trajectory, with driver shipments exceeding expectations at 65,000 units, reflecting an 8% quarter-over-quarter and 11% year-over-year increase. The company's gross margin improved by 240 basis points year-over-year, alongside a significant rise in operating margin by 570 basis points year-over-year, indicating enhanced operational efficiency and profitability. Furthermore, management has reaffirmed its revenue guidance for 2025 while raising earnings per share guidance, suggesting optimism for continued growth driven by market share gains and new product developments in both the healthcare and non-healthcare segments.

Bears say

Masimo Corp's financial outlook is hindered by declining organic revenue in both its Healthcare and Non-Healthcare segments, leading to revised projections for 2025 and 2026 that reflect significant decreases in expected revenue. The company's growth is anticipated to slow into the mid-single digits, primarily due to lost market share in monitoring technologies and lackluster new product sales, which could adversely affect margins and earnings performance. Additional risks such as manufacturing challenges and potential impacts from GLP-1 weight loss drugs further complicate Masimo's financial position, suggesting a challenging road ahead for the company.

Masimo (MASI) has been analyzed by 19 analysts, with a consensus rating of Buy. 42% of analysts recommend a Strong Buy, 37% recommend Buy, 21% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 19 analysts, Masimo (MASI) has a Buy consensus rating as of Aug 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $126.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $126.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.